Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Orchid Eyes European Purchase
10:54 AM MDT | July 27, 2007 | Chemical Week Editorial Staff
Pharma company Orchid Chemicals & Laboratories (Chennai, India) says it intends to make an acquisition in Europe as part of a strategy to gain access to the high-value international generic injectable drugs market. Orchid says it may issue shares to pay for the planned acquisition, depending on the size of the company that it buys. Orchid says it has yet to identify an acquisition target, but that it is looking for a “front-end” company with a sales force as well as divisions for quality control and post-marketing...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee